CARACO PHARMACEUTICAL LABORATORIES LTD 4
4 · CARACO PHARMACEUTICAL LABORATORIES LTD · Filed Apr 9, 2008
Insider Transaction Report
Form 4
MOVENS DANIEL H
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2008-04-07$18.53/sh−218$4,040→ 33,582 total - Sale
Common Stock
2008-04-08$18.10/sh−380$6,878→ 30,701 total - Sale
Common Stock
2008-04-08$18.11/sh−101$1,829→ 30,600 total - Sale
Common Stock
2008-04-08$17.82/sh−100$1,782→ 32,181 total - Sale
Common Stock
2008-04-08$17.91/sh−400$7,164→ 31,581 total - Sale
Common Stock
2008-04-07$18.40/sh−400$7,360→ 34,500 total - Sale
Common Stock
2008-04-07$18.49/sh−200$3,698→ 34,200 total - Sale
Common Stock
2008-04-07$18.59/sh−19$353→ 32,981 total - Sale
Common Stock
2008-04-07$18.55/sh−300$5,565→ 33,182 total - Sale
Common Stock
2008-04-07$18.56/sh−182$3,378→ 33,000 total - Sale
Common Stock
2008-04-07$18.36/sh−100$1,836→ 34,900 total - Sale
Common Stock
2008-04-08$18.16/sh−300$5,448→ 30,300 total - Sale
Common Stock
2008-04-08$17.96/sh−200$3,592→ 31,381 total
Footnotes (1)
- [F1]On March 14, 2008, the reporting person entered into a Rule 10b5-1 trading plan to sell up to 30,000 shares of common stock for estate and tax planning objectives. The reported sales were effected pursuant to such Rule 10b5-1 plan.